Go Pro
NASDAQ:BFRG

Bullfrog AI Q2 2025 Earnings Report

Bullfrog AI logo
$0.60 -0.04 (-6.78%)
As of 03:49 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Bullfrog AI EPS Results

Actual EPS
-$0.15
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Bullfrog AI Revenue Results

Actual Revenue
$0.03 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Bullfrog AI Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Wednesday, August 13, 2025
Conference Call Time
7:00AM ET

Upcoming Earnings

Bullfrog AI's Q3 2026 earnings is estimated for Friday, November 13, 2026, based on past reporting schedules, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

Bullfrog AI Earnings Headlines

Bullfrog AI (NASDAQ:BFRG) CEO Acquires $45,000.00 in Stock
Bezos… DOOMED
A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing December 8th.tc pixel
BullFrog AI Stock Surges Wednesday: What's Happening?
See More Bullfrog AI Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Bullfrog AI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bullfrog AI and other key companies, straight to your email.

About Bullfrog AI

Bullfrog AI (NASDAQ:BFRG) Holdings, Inc. is a biotechnology and technology company that applies artificial intelligence and machine learning to drug development and precision medicine. The company focuses on helping pharmaceutical, biotechnology and healthcare organizations analyze complex biomedical data and identify insights that may support research and clinical decision-making.

Its primary platform, bfLEAP, is designed to process and analyze large, multidimensional datasets, including clinical, genomic and other healthcare-related information. BullFrog AI provides data analytics and related services intended to assist with drug discovery, clinical development, patient stratification and the evaluation of potential therapeutic opportunities.

Based in the United States, the company operates in the life sciences and healthcare technology sectors and serves organizations seeking to incorporate advanced analytics into biomedical research. BullFrog AI became a publicly traded company in 2023. Publicly available information about its geographic reach and detailed leadership structure is limited.

View Bullfrog AI Profile